Pro-Pharmaceuticals, Medidata to Implement EDC in Phase II Trial

Medidata Solutions, a global electronic clinical data management solutions provider, will provide Pro-Pharmaceuticals, a developer of novel carbohydrate compounds that enable the targeted delivery of chemotherapy drugs to cancer cells, with state-of-the-art electronic data capture technology for Pro-Pharmaceuticals' Phase II clinical trial.

Pro-Pharmaceuticals has initiated a Phase II clinical trial to evaluate efficacy and safety of Davanat/5-FU when administered in monthly cycles as a third-line therapy for metastatic colorectal cancer.